NLM Logo

KU-32 compound MeSH Supplementary Concept Data 2024


MeSH Supplementary
KU-32 compound
Unique ID
C581040
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C581040
Entry Term(s)
N-(7-((2R,3R,4S,5R)-3,4-dihydroxy-5-methoxy-6,6-dimethyl-tetrahydro-2H-pyran-2-yloxy)-8-methyl-2-oxo-2H-chromen-3-yl)acetamide
Registry Number
0
Heading Mapped to
Novobiocin / *analogs & derivatives
Frequency
6
Note
a novobiocin-based Hsp90 inhibitor, safe for human islets and improves in vitro insulin secretion and viability
Source
Exp Diabetes Res. 2012;2012() (dup#98):671673
Indexing Information
Diabetes Mellitus, Type 2
Neuroprotective Agents
Date of Entry
2013/05/13
Revision Date
2014/02/28
KU-32 compound Preferred
N-(7-((2R,3R,4S,5R)-3,4-dihydroxy-5-methoxy-6,6-dimethyl-tetrahydro-2H-pyran-2-yloxy)-8-methyl-2-oxo-2H-chromen-3-yl)acetamide Broader
page delivered in 0.005s